Worth Venture Partners’s Cellectar Biosciences CLRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-23,130
| Closed | -$1.92M | – | 71 |
|
|
2023
Q4 | $1.92M | Buy |
23,130
+13,826
| +149% | +$1.15M | 1.04% | 34 |
|
|
2023
Q3 | $737K | Sell |
9,304
-1,146
| -11% | -$90.8K | 0.44% | 62 |
|
|
2023
Q2 | $611K | Sell |
10,450
-770
| -7% | -$45K | 0.33% | 67 |
|
|
2023
Q1 | $485K | Hold |
11,220
| – | – | 0.24% | 86 |
|
|
2022
Q4 | $576K | Buy |
11,220
+9,832
| +708% | +$504K | 0.34% | 71 |
|
|
2022
Q3 | $140K | Sell |
1,388
-139
| -9% | -$14K | 0.09% | 123 |
|
|
2022
Q2 | $225K | Hold |
1,527
| – | – | 0.13% | 109 |
|
|
2022
Q1 | $315K | Buy |
1,527
+841
| +123% | +$173K | 0.15% | 96 |
|
|
2021
Q4 | $137K | Buy |
+686
| New | +$137K | 0.07% | 109 |
|
|
2020
Q4 | – | Sell |
-585
| Closed | -$218K | – | 94 |
|
|
2020
Q3 | $218K | Sell |
585
-745
| -56% | -$278K | 0.18% | 85 |
|
|
2020
Q2 | $511K | Buy |
+1,330
| New | +$511K | 0.25% | 58 |
|